Evidence map›Paper›PMID 41050245›Full record

ArticleActa clinica Croatica2024

DISTRIBUTION OF RESPIRATORY VIRUSES IN CHILDREN ADMITTED TO PEDIATRIC INTENSIVE CARE UNIT.

Gokhan Ceylan, Ozlem Sandal, Ferhat Sari, Rana Isguder, Ahu Kara, Gamze Gülfidan, Yuce Ayhan, Ilker Devrim, Hasan Ağın

Abstract read
In one paragraph

Article in Acta clinica Croatica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gokhan Ceylan1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Ozlem Sandal1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Ferhat Sari1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Rana Isguder1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Ahu Kara1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Gamze Gülfidan1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Yuce Ayhan1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Ilker Devrim1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.
Hasan Ağın1Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 2Department of Pediatric Infectious Diseases Unit, Dr. Behçet Uz Children's Hospital, Izmir, Turkey; 3Department of Infectious Diseases and Clinical Microbiology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lower respiratory tract infection (LRTI) is common in children and associated with high morbidity and mortality. The aim of this study was to determine the distribution of respiratory viruses leading to admission of a child with the diagnosis of LRTI to pediatric intensive care unit (PICU). The distribution of viral pathogens was determined using viral multiplex polymerase chain reaction (PCR) in children with LRTI admitted to PICU at a tertiary-level reference pediatric hospital. The LRTI patients without a positive viral multiplex PCR finding were excluded from the study. Most patients were under 2 years of age (78.3%), and the most common viral pathogen resulting in PICU admission due to viral LRTI was RSV A/B (32.8%). Thirty three patients had an underlying disease. Ten (16.6%) patients required invasive mechanical ventilation (IMV), 37 (61.6%) required high-flow oxygen therapy (HFOT), and two patients (3.3%) progressed to pediatric acute respiratory distress syndrome (PARDS). Underlying chronic disease presence was the highest in the IMV group with 90%, which decreased to 54% and 30.7% in the HFOT and standard oxygen treatment groups, respectively (p=0.018). The patients with IMV requirements had significantly longer hospital stay (median 8 days, range 6-13 days) compared to HFOT group (median 6 days, range 4-7.5 days] and regular oxygen treatment group (median 3 days, range 2-3.5 days) (p<0.001). The use of multiplex PCR for respiratory viruses may help in discriminating etiologic viral agents in patients admitted to PICU and estimating possible complications associated with viral-specific disease. The presence of an underlying disease in a patient with viral LRTI affects the treatment level, and treatment level affects the duration of PICU stay.

Indexed as

Intensive Care Units, PediatricRespiratory Tract InfectionsChildChild, PreschoolFemaleHumansInfantMaleMultiplex Polymerase Chain ReactionRespiration, ArtificialHigh-flow oxygen therapyMechanical ventilationMultiplex PCRPediatric intensive care unitViral infection

Identifiers

PMID41050245
PMCPMC12490507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.